Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

April 30, 2006

Study Completion Date

May 31, 2007

Conditions
Major Depressive Disorder
Interventions
DRUG

Quetiapine fumarate

Trial Locations (37)

Unknown

Research Site, Little Rock

Research Site, Newport Beach

Research Site, Northridge

Research Site, Oceanside

Research Site, Santa Ana

Research Site, Denver

Research Site, Norwich

Research Site, Washington D.C.

Research Site, Jacksonville

Research Site, Winter Park

Research Site, Atlanta

Research Site, Smyrna

Research Site, Eagle

Research Site, Oak Brook

Research Site, Wichita

Research Site, Shreveport

Research Site, Farmington Hills

Research Site, St Louis

Research Site, Las Vegas

Research Site, Cherry Hill

Research Site, Clementon

Research Site, Brooklyn

Research Site, New York

Research Site, Staten Island

Research Site, Raleigh

Research Site, Cincinnati

Research Site, Tulsa

Research Site, Portland

Research Site, Norristown

Research Site, Memphis

Research Site, Austin

Research Site, Dallas

Research Site, San Antonio

Research Site, Bellevue

Research Site, Seattle

Research Site, Charleston

Research Site, Brown Deer

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY